|
^ TYME: Intraday Hourly Forecast Similar Waves GapOpen Research Timing Gains Losses Strategies Practice |
Wed. Jan. 24, 2018 | Trading Signals: TYME Stock Price Prediction and Forecast (Tue. Aug. 15, 2017 - Fri. Jan. 26, 2018)(Tyme Technologies)
| TYME latest price $5.3200 (3.3%) ($4.7300 - $5.3600) on Wed. Jan. 24, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.55% (three month average) | RSI | 35 | Latest Price | $5.3200(3.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TYME declines -5.4% a day on average for past five trading days. | Weekly Trend | TYME declines -7.7% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TYME advance at 0% a week (0% probability) VIXM(21%) REMX(-3%) VWO(-56%) EWG(-39%) EWP(37%) | Factors Impacting TYME price | TYME will decline at least -3.775% in a week (0% probabilities). JETS(-56%) OIH(87%) EWY(21%) EWP(37%) EWG(-39%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.775% (StdDev 7.55%) | Hourly BBV | 0 () | Intraday Trend | 3.1% | | | |
|
1 - 5 Day Possible Target | $-8.47(-259.21%) | Resistance Level | $6.43 | 5 Day Moving Average | $5.76(-7.64%) | 10 Day Moving Average | $6.26(-15.02%) | 20 Day Moving Average | $6.43(-17.26%) | To recent high | -27.1% | To recent low | 4.3% | Market Cap | $907m | | | | Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. With the development of TYME-18 and TYME-19, the Company believes that it is also emerging as a leader in the development of bile acids as potential therapies for cancer and COVID-19. | $. TYME price fluctuates within 7.78% (three month std-dev: 7.55%) daily (68% of days). Sample size 6 Average positive next day return: 7.14%(50%) Average negative next day return: -3.04%(50%)
Sample size 6 Average positive next three day return: 11.41%(33%) Average negative next three day return: -6.25%(67%)
Sample size 6 Average positive next weekly return: 13.09%(33%) Average negative next weekly return: -17.25%(67%)
Analysis News Options Weekly Chart Daily Chart 2 Month Daily Chart > 20180224 i | Date | ema100 | ema20 | ema10 | ema5 | Slow Hourly Trend | Fast Hourly Trend | Close | Pattern | Trade | P | SMA5 BBV | WTF | lsma10 Trend | ema5 Trend | ema10 Trend | Volume millions | Quarterly Strength | 100 Daily Trend | Daily Trend Force | Daily StdDev | Hourly BBV | BBV | RSI | VIXCD |
---|
1 | Jan_24_2018 | 6.42 | 6.43 | 6.26 | 5.76 | 5.77 | 5.36 | 5.32(3.3%) | DP | OpenShort | -75 | -0.9 | -32 | -490 | -19 | -69 | 0.35 | 62% | -0.77 | -23.3 | 7.55% | 0 | -2.2 | 35 | -1.4 | | | | | 2 | Jan_23_2018 | 6.47 | 6.5 | 6.41 | 6.09 | 6.12 | 5.81 | 5.15(-15.3%) | DT | OpenShort | -75 | -2.2 | -25 | -340 | -18 | -46 | 0.33 | 62% | -0.46 | 27.3 | 7.54% | 0 | -3.1 | 35 | 0.1 | | | | | 3 | Jan_22_2018 | 6.5 | 6.62 | 6.54 | 6.43 | 6.4 | 6.18 | 6.08(-0.16%) | DT | OpenShort | -75 | -1.2 | -12 | -250 | -8 | -22 | 0.18 | 74% | 0.15 | 138 | 7.26% | 0 | -1.8 | 49 | 0.9 | | | | | 4 | Jan_19_2018 | 6.49 | 6.66 | 6.63 | 6.55 | 6.6 | 6.43 | 6.09(-0.98%) | DT | OpenShort | -75 | -1.6 | -7 | -160 | -8 | -5 | 0.65 | 74% | -0.15 | 233.8 | 7.32% | 0 | -2 | 53 | 1 | | | | |
|
|